Axcella Health Inc. (NASDAQ:AXLA) management will conduct a conference call for 12th November 2020 at 8:30 AM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.axcellahealth.com
To participate in the conference call, local and international callers can dial (866) 652-5200 U.S. or (412) 317-6060 Toll Number
Earnings Expectation
Axcella Health Inc. is set to announce third quarter earning results on Thursday 12th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, AXLA to report 3Q20 loss of $ 0.41 per share. For the full year, analysts anticipate loss of $ 1.93 per share bottom line.
Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.
